1. Guidance for Presenters
2. Guidance for Panelists
3. Schedule of Panels

A. Guidance for Presenters (see How to Prepare for a Panel for further advice)

• Where and When: See Schedule
  Presenters should be in the room at least 5 minutes before the time of their panel. Non-presenters (and panelists) are welcome at any time.
   
• Duration of presentation: Up to seven minutes and no more. At six minutes, you'll hear a courteous tinkle of a bell. At seven minutes, a bone-shaking clang will stop your presentation if it has not already concluded. If you're in the middle of a sentence, you'll be permitted to complete the sentence (with no more than one conjunction), but that's it.
   
• Duration of question and answer period: Up to eight minutes, marked by a bell. Questions will be posed by the panel concerning the presentation and the written proposal.
   
• Loading presentations: There won't be time to download your presentation. It must be on the computer before the panels begin. This can be done in either of two ways:
   
  • E-mail your presentation to me by 15 minutes before the beginning of the panel
  • Bring your presentation on a memory device by 15 minutes before the beginning of the panel
  
  Do not expect to download it from your e-mail or upload it on the spot from your memory device.
   

B. Guidance for Panelists

• Reviewers: Each proposal has been assigned a primary reviewer and a secondary reviewer, noted in the schedule. The primary reviewer will begin the discussion after the presentation. All panelists are invited, nay, urged to join in as well.
   
• Goals of the proposal: Please see How to Write a Research Proposal to see the goals presenters were asked to address. If you like, you can also take a look at an example of a proposal.
   
• Goals of presentation: Please see How to Give a Presentation Focused on an Experiment to see the goals presenters were asked to address.
   
• Goals of the course: The primary goal of the course was to bring students into the scientific process of approximating truth, giving due weight to what has been observed, limited by how it was observed, and distinguishing observation from mere assertion.
   
• Goals of the review process: Please consider whether the proposal and presentation has addressed the general goals of the course and the specific goals of presentations and proposals. For example, a generally useful question would be "How do you know that [some assertion] is true?". If the proposal and presentation does not make clear that the presenter understands the principle behind the proposed experiment, you might through probing questions give the presenter an opportunity to display (or perhaps discover) such understanding.
   
• Feedback: The eight minutes of questioning will by itself provide valuable feedback to the presenter. You're certainly invited to provide written feedback as well. Presenters have until Sunday, May 15, to revise their proposals, if they wish.
   
• Thanks: Please accept them for the bracing experience you've given fledgling molecular biologists.

C. Schedule of Panels

Panel I: Tuesday, May 10, 9:30 - 10:30 AM. Life Sciences Building Room 253 (see map)
Panelists: James Lister, Joyce Lloyd, Ann Rice

Kelly Flounlacker	How does the membrane environment of Neurofascin 155 impact the inflammatory response of Microglial Cells? Primary: Ann Rice, Secondary: James Lister       (Presentation)
Damien Islek	PTK7 domain involvement in planar cell polarity pathway regulation of zebrafish CoPA neurons axon pathfinding Primary: James Lister, Secondary: Joyce Lloyd       (Presentation)
Steven Jermstad	Epigenetic effects of the Krüppel-like Transcription Factor 1 on DNA methylation Primary: Joyce Lloyd, Secondary: Ann Rice       (Presentation)

Panel II: Wednesday, May 11, 9:30 - 10:30 AM. Harris Hall Room 3112 (see map)
Panelists: John Bigbee, Vlad Vladimirov, Wenheng Zhang

Robbie Kalish	How do acetamiprid and imidacloprid bind to the acetylcholine receptor alpha subunit of Apis mellifera? (original, revised) Primary: John Bigbee, Secondary: Vlad Vladimirov       (Presentation)
Ellen Korcovelos	Down regulation of miRNAs by mutated FOXP2 Primary: Vlad Vladimirov, Secondary: Wenheng Zhang       (Presentation)
Herleen Mokha	Understanding the role of the PACE/furin site and apoptosis in terms of Factor 8 production in regards to hemophilia A therapy Primary: Wenheng Zhang, Secondary: John Bigbee       (Presentation)

Panel III: Wednesday, May 11, 4:00 - 5:00 PM. Harris Hall Room 3112 (see map)
Panelists: Gail Christie, Bernice Huang, Maria Rivera

Sarah Adkins	The ReIEB toxin-antitoxin system and its impact on the ability of Lactobacillus iners to survive in conditions associated with bacterial vaginosis Primary: Gail Christie, Secondary: Bernice Huang       (Presentation)
Sam Foltz	Identification of highly conserved Bacillus phage orfs of unknown function Primary: Gail Christie, Secondary: Maria Rivera       (Presentation)
Suquoia Mosby	What genes in Bacteroides fragilis contributes to the tumoricidal effect in colonrectal cancer? Primary: Bernice Huang, Secondary: Maria Rivera       (Presentation)
Trish Turpin	Vaginal TM7 and the absorption of amino acids Primary: Maria Rivera, Secondary: Bernice Huang       (Presentation)

Panel IV: Thursday, May 12, 4:00 - 5:00 PM. Harris Hall Room 3112 (see map)
Panelists: Teshell Ponteen Greene, Allison Johnson, Glen Kellogg

Mike Livingston	BPTF role in PI3K-AKT pathway in breast cancer Primary: Teshell Ponteen Greene, Secondary: Allison Johnson       (Presentation)
Dan Nacu	Chemical properties that affect binding of enzyme-inhibiting drugs to enzymes Primary: Allison Johnson, Secondary: Glen Kellogg       (Presentation)
Amanda Rutledge	Lysis of shiga toxin-producing Escherichia coli by delivery of Crispr/Cas9 cascade coding cosmid targeting Stx 1 and Stx 2 genes via lambda Primary: Allison Johnson, Secondary: Teshell Ponteen Greene       (Presentation)
Gus Thomas	CRISPR/Cas9 as a tool for creation of p53 knock-outs in human glioma cells Primary: Glen Kellogg, Secondary: Teshell Ponteen Greene       (Presentation)

Panel V: Friday, May 13, 11:30 - 12:30 PM. Harris Hall Room 3112 (see map)
Panelists: Billy Budd, Stacey Wahl, Greg Walsh

Bryce Kirby	Inhibition of the p53 tumor suppressor by MDM2 and the role miRNA plays in p53 gene expression and regulation Primary: Billy Budd, Secondary: Stacey Wahl       (Presentation)
Harshita Nangunuri	Measuring the effect of silencing the APP gene and stimulating the CaMKII pathway on synaptic plasticity in Alzheimer's Disease Primary: Stacey Wahl, Secondary: Greg Walsh       (Presentation)
Morgan Van Driest	The role of desmoplakin during epidermal development Primary: Greg Walsh, Secondary: Billy Budd       (Presentation)

Panel VI: Friday, May 13, 1:00 - 2:00 PM. Harris Hall Room 3112 (see map)
Panelists: Keith Baker, Nathalie Houssin, Dorne Yager

Shray Amin	The effect of suppressing HIF1A on the expression of HIF2A Primary: Dorne Yager, Secondary: Nathalie Houssin       (Presentation)
Miral Mahmood	Importance of SPH2 in RAS/MAPK signalling pathway in NF1 nondystrophic scoliosis Primary: Nathalie Houssin, Secondary: Keith Baker       (Presentation)
Nate Stearrett	Measurement of the expression of the ALOX15 gene in wounds undergoing negative pressure wound therapy Primary: Keith Baker, Secondary: Dorne Yager       (Presentation)